期刊文献+

α-2b干扰素治疗流行性腮腺炎合并睾丸炎35例疗效观察 被引量:1

Clinical efficacy of α-2b interferon in the treatment of 35 cases of epidemic mumps orchitis
下载PDF
导出
摘要 目的:探讨流行性腮腺炎合并睾丸炎有效的治疗方法。方法:选择2008年11月~2010年8月本院住院患者60例,随机分成两组,治疗组35例,对照组25例,治疗组应用α-2b干扰素(凯因益生,北京凯因生物技术有限公司)3000000U每日1次肌注,连用5d;对照组给予利巴韦林注射液10mg/(kg·d),最大量至600mg,加入5%葡萄糖液中静滴,连用7d。观察两组疗效。结果:治疗组患者退热时间、腮腺及睾丸消肿时间、血、尿淀粉酶恢复时间显著缩短,分别为(1.6±0.8)、(2.7±2.9)、(4.3±1.6)、(3.0±1.1)、(4.1±1.9)d、明显优于对照组的(2.4±1.0)、(8.0±5.0)、(6.2±2.8)、(5.1±1.9)、(6.4±1.1)d,经t检验,P<0.01。治疗过程中未发现不良反应。结论:肌内注射小剂量α-2b干扰素治疗腮腺炎合并睾丸炎是一种安全有效的方法。 Objective: To explore the effective treatment of epidemic mumps orchitis. Methods: Sixty patients from November 2008 to August 2010 were slected and were divided into treatment group and control group, the treatment group 35 cases were given 3 000 000 U of Interferon α-2b (Kain prebiotics, by Beijing Kain Biotechnology Co., Ltd.) intramuscularly once a day for 5 days and 25 patients in the control group were given 10 mg/(kg.d) ribavirin injection with maximum dose of 600 mg in combination with 5% glucose solution intravenously for 7 days. Results: Fever clearance time, parotid gland and testicular swelling subsidence time and blood and urine amylase recovery time were (1.6±0.8), (2.7±2.9), (4.3±1.6), (3.0±1.1) and (4.1±1.9) days respectively in the treatment group and were significantly shorter than (2.4±1.0), (8.0±5.0)s, (6.2±2.8), (5.1±1.9) and (6.4±1.1) days in the control group. The differences were found to be significant in t-test (P〈0.01). No adverse reactions were found in the course of treatment. Conclusion: Intramuscular injection of small doses of interferon α-2b is an effective treatment of mumps orchitis.
作者 鞠俊玲
出处 《中国当代医药》 2011年第35期83-83,85,共2页 China Modern Medicine
关键词 腮腺炎 睾丸炎 Α-2B干扰素 疗效观察 Mumps Orchitis α-2b interferon Efficacy observation
  • 相关文献

参考文献4

  • 1鲁继荣,乔红梅.病毒性疾病诊断与治疗[J].临床儿科杂志,2006,24(7):548-552. 被引量:10
  • 2陈新谦,金有豫,汤光.新编药物学[M].15版.北京:人民卫生出版社,2004:394,569.
  • 3Ku Ju,Kim YH,Jeon YS,et al.The preventive effect of systemic treatment with interferonalpha 2B for intertility form mumps orchitis [J].BJV Int, 1999,84(7):839-842.
  • 4Jalal H,Bahadur G,Knowles W,et al,Mumps epididy moorchitis with prolonged delection of virus in semen and the developmet of antisperm antibodies[J].Jmed Virol,2004,73(l): 147-150.

二级参考文献15

  • 1黄强,应可净.严重急性呼吸综合征的诊断、治疗现状和展望[J].国外医学(呼吸系统分册),2005,25(7):551-555. 被引量:5
  • 2Tree JA,Richardson C,Fook AR,et al. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. J Med Virol,2001,65 : 163-170.
  • 3Noyola DE, Paredes A J, Clark B, et al. Evaluation of a neu- raminidase detection assay for the rapid influenza A and B virus in children. Pediatr Dev Pathol,2000,3:162-167.
  • 4Noyola DE, Clark B, O' Donnell FT, et al. Comparison of a new neuraminidase detection assay with an enzyme immunnfluores-cence,and culture for rapid of influenza A and B viruses innasal specimens. J Clin Microbiol, 2000,38:1161-1165.
  • 5Tsang KW,Ho PL,Ooi GC,et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med,2003,348(20):1977-1985.
  • 6Cumulative number of reported probable cases of severe acute respiratory syndrome (SARS). http://www.who.int/csr/sars/country/2003-05 - 13/en/index. html.
  • 7Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza. JAMA,2000,283 : 1016-1024.
  • 8Deng WW. The importance of early diagnosis of influenza.Clin J Tuberc Repir Dis, 2002,25 : 645-646.
  • 9Kaiser L, Wat C, Mills T, et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med ,2003,163 : 1667-1672.
  • 10de Jong MD ,Tran TY ,Truong HK, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med, 2005,353 (25) : 2667-2672.

共引文献110

同被引文献29

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部